BioLife Solutions Inc. signed a definitive merger agreement to acquire Global Cooling Inc., which is operating as Stirling Ultracold, a privately held manufacturer of ultra low temperature mechanical freezers.

According to BioLife Solutions, a developer and supplier of bioproduction products and services for cell and gene therapies, combining Stirling’s -4 to -122°F (-20 to -86°C) freezer systems with its current liquid nitrogen freezers allows the company to address the cold-chain infrastructure critical for personalized medicine. Demand for the freezers is being fueled by the storage requirements for COVID-19 vaccines.